LATEST
PEER-REVIEWED PUBLICATIONS BY OUR
SCIENCE TEAM

DR. VASILIS PASPALIARIS

PROF. GEORGE KOLIOS

DR. DONALD ANDERSON

A short-list of the latest relevant publications produced by our science team:

• Pan-Cancer Insights: A Study of Microbial Metabolite Receptors in Malignancy Dynamics

• P1242 Pediatric IBD microbiome and microbial profiles formed within the family

• P146 Latent activation of the extrinsic coagulation pathway in patients with ulcerative colitis

• Niclosamide Attenuates Inflammation-Associated Profibrotic Responses in Human Subepithelial Lung Myofibroblasts

• Identifying Microbiome Dynamics in Pediatric IBD: More than a Family Matter

• Remission of refractory Crohn's disease with anti‐IL‐12/23 therapy in a patient undergoing hemodialysis: a case report

• Special Issue “Gut Microbiota, Inflammatory Bowel Diseases, and Therapeutic Targets”

• Su1738 ONSCOSTATIN-M INDUCES THE EXPRESSION OF CHEMOTACTIC FACTORS’MRNA BY INTESTINAL SUBEPITHELIAL MYOFIBROBLASTS IN A PRO-INFLAMMATORY ENVIRONMENT.

• Role of Lactiplantibacillus plantarum UBLP-40, Lactobacillus rhamnosus UBLR-58 and Bifidobacterium longum UBBL-64 in the Wound Healing Process of the …

• Stromal and immune cell interactions in intestinal inflammation and fibrosis

• P021 Microbial metabolite receptors as mediators of pathogenic processes in Inflammatory Bowel Disease

• P041 The upregulation of tissue factor in colonic mesenchymal cells in active ulcerative colitis is associated with severe and resistant to treatment disease, but tofacitinib …

• Stem Cell Therapies for Gastrointestinal Anastomotic Healing: A Systematic Review and Meta-Analysis on Results from Animal Studies

• Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?

• The probiotic strains Bifidobacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii regulate wound healing and …

• The Probiotic Strains Bifidοbacterium lactis, Lactobacillus acidophilus, Lactiplantibacillus plantarum and Saccharomyces boulardii Regulate Wound Healing and …

• Amniotic fluid-derived mesenchymal stem/stromal cell-derived secretome and exosomes improve inflammation in human intestinal subepithelial myofibroblasts

• The probiotic mix of Saccharomyces boulardii, Bifidbacterium lactis, Lactobacillus acidophilus, Lactobacillus plantarum regulates chemokine responses in human intestinal …

• Biomarkers in Inflammatory Bowel Diseases: Predicting the Indication and the Effect of Biologics.

• The effect of Oncostatin M on human intestinal organoids

• Mucosal Microbiota Composition Predicts Infliximab Response in Inflammatory Bowel Diseases

• P093 Probiotic strains Lactobacillus plantarum and Saccharomyces boulardii influence the fibrotic responses of human intestinal subepithelial myofibroblasts

• Response to anti-α4β7 blockade in patients with ulcerative colitis is associated with distinct mucosal gene expression profiles at baseline

• Probiotics in intestinal mucosal healing: a new therapy or an old friend?

• Colon Cancer Progression Is Reflected to Monotonic Differentiation in Gene Expression and Pathway Deregulation Facilitating Stage–specific Drug Repurposing

• Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: a review

• Development of a human intestinal organoid model for in vitro studies on gut inflammation and fibrosis

• The IBD-F patient self-assessment scale accurately depicts the level of fatigue and predicts a negative effect on the quality of life of patients with IBD in clinical remission

• P045 Oncostatin M induces strong fibrotic and chemokine responses from primary colonic subepithelial myofibroblasts

• P067 The effect of a probiotic mix on mucosal healing and fibrotic responses in healthy colonic subepithelial myofibroblasts

• Prognostic role of RASSF1A, SOX17 and Wif-1 promoter methylation status in cell-free DNA of advanced gastric cancer patients

• Fibrotic expression profile analysis reveals repurposed drugs with potential anti-fibrotic mode of action

• Association between SOX17, Wif-1 and RASSF1A promoter methylation status and response to chemotherapy in patients with metastatic gastric cancer

• Research Article Development of a Human Intestinal Organoid Model for In Vitro Studies on Gut Inflammation and Fibrosis

• Nutritional supplements during gestation and autism spectrum disorder: what do we really know and how far have we gone?

• The interplay between mucosal microbiota composition and host gene-expression is linked with infliximab response in inflammatory bowel diseases

• P009 The innate cytokines IL-1α and TNF-α induce the expression of Oncostatin M and its type II receptor in human colonic subepithelial myofibroblasts

• Is there place for nutrition in the treatment of children with autism spectrum disorder?

• IL-17 regulates expression of chemotactic chemokines in human colonic subepithelial myofibroblasts

• Incidence and significance of fatigue in patients with IBD

• Control of Helicobacter pylori with engineered probiotics secreting selective guided antimicrobial peptides

• Targeted mosquitocidal toxins

• In situ treatment of H. pylori infection in mice stomach with bioengineered probiotic bacteria releasing guided Antimicrobial peptides

• In vitro inhibition of H. pylori in a preferential manner using bioengineered L. lactis releasing guided Antimicrobial peptides

• Repurposing a drug targeting peptide for targeting antimicrobial peptides against Staphylococcus

• The use of a virus-derived targeting peptide to selectively kill staphylococcus bacteria with antimicrobial peptides

• The use of a virus-derived targeting peptide to selectively kill staphylococcus bacteria with antimicrobial peptides